ClinicalTrials.gov
ClinicalTrials.gov Menu

Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and Splenectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02757690
Recruitment Status : Completed
First Posted : May 2, 2016
Last Update Posted : May 2, 2016
Sponsor:
Collaborator:
Olympus
Information provided by (Responsible Party):
Song Cheol Kim, Asan Medical Center

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Traditionally, laparoscopy has been based on 2-dimensional (2D) imaging, which has represented a considerable challenge for those approaching this technique. Thus, 3-dimensional (3D) visualization technology for laparoscopy has been proposed, since the early 1990s, as a way to facilitate laparoscopic performance. However, early 3D laparoscopic technology was limited in terms of image quality, so that its use had not been implemented. More recently, industry has developed novel 3D systems where the imaging is similar to stereoscopic vision, in which the depth perception is achieved by different unique images received by each eye. Thus, more recent studies have suggested a possible advantage provided by these new 3D systems during laparoscopic performance. However, comparative assessments of new generation 3D vs 2D laparoscopy remain limited, especially in the hepatobiliary and pancreatic field.

To assess the benefits and harms of use of three dimensional systems versus two dimensional systems during laparoscopic distal pancreatectomy.


Condition or disease Intervention/treatment Phase
Benign Neoplasm of Body of Pancreas Benign Neoplasm of Tail of Pancreas Device: 3-dimensional distal pancreatectomy Device: 2-dimensional distal pancreatectomy Phase 4

Detailed Description:

Procedures

  1. the investigators will take the patient consent for this clinical trial.
  2. The participants will be divided with two groups with block randomized method
  3. Skillful pancreatic surgeon will perform 2D or 3D laparoscopic distal pancreatectomy.
  4. The participants will be monitor the intraoperative and postoperative course.

Data collection

  1. operation video : operation time, number of errors (missed grasp, loss of material)

    1. Segmental operation time according to procedure
    2. Numbers of errors during operation

  2. clinical parameters:

    1. Blood examination : complete blood count (hemoglobin, white blood cell count), amylase, lipase, etc.
    2. Radiological examination: X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), etc
    3. Medical records : hospital stay after operation, the time to eating, pathologic examination

  3. Subjective scoring in the view of operator, 1st assist.

    1. Scoring for imaging quality
    2. Scoring for harms of 3D/2D laparoscopic system
    3. Scoring for overall demand

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Official Title: Validation and Verification of 3 Dimensional Laparoscopic System in Laparoscopic Distal Pancreatectomy & Splenectomy
Study Start Date : January 2015
Actual Primary Completion Date : February 2016
Actual Study Completion Date : February 2016
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: 2-dimenasional distal pancreatectomy
device: 2 dimensional laparoscopy of Olympus
 Device: 2-dimensional distal pancreatectomy
2D laparoscopy
Other Name: 2D
Experimental: 3-dimenasional distal pancreatectomy
device : 3 dimensional laparoscopy of Olympus
 Device: 3-dimensional distal pancreatectomy
3D laparoscopy
Other Name: 3D


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Operation time [ Time Frame: expected duration: 200mins (for each operation) ]
    The unedited videos of the operations will be assessed from start to end of the operation by two clinicians. The average of operation time will be compare according to 2D versus 3D laparoscopic system.


Secondary Outcome Measures :
  1. Numbers of errors during operation [ Time Frame: During operation (expected duration: 200mins) ]
    The investigators will check the error number of operator during operation with review the video record of the operation

  2. Subjective scoring in the view of operator, 1st assist [ Time Frame: During operation (expected duration: 200mins) ]
    The investigators will check the subjective scoring of operator and 1st assist during operation. For example, depth perception, sharpness, visual strain, headache, etc.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • BMI > 30 (Kg/m2)
  • History of severe or recurrent pancreatitis
  • Mass size > 10cm
  • History of low abdomen major operation
  • Additional resection for extra-pancreatic organ

Exclusion Criteria:

  • Participants refusal.
  • Additional resection dependent on pathological examination in intraoperative or postoperative period.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02757690


Sponsors and Collaborators
Asan Medical Center
Olympus
Investigators
Principal Investigator: Songcheol Kim, MD PhD Asan Medical Center
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Song Cheol Kim, professor, Asan Medical Center
ClinicalTrials.gov Identifier: NCT02757690     History of Changes
Other Study ID Numbers: 2D vs 3D LDPS comparison
First Posted: May 2, 2016    Key Record Dates
Last Update Posted: May 2, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
 Neoplasms by Site
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases